When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
Gespeichert in:
| Veröffentlicht in: | Aging clinical and experimental research 2022-12, Vol.34 (12), p.3171-3177 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3177 |
|---|---|
| container_issue | 12 |
| container_start_page | 3171 |
| container_title | Aging clinical and experimental research |
| container_volume | 34 |
| creator | Mujahid, Nadia Rajan, Ashna Abul, Yasin Vura, Naga Venkata Rama Krishna Neupane, Iva LaPlante, Kerry Gravenstein, Stefan |
| description | |
| doi_str_mv | 10.1007/s40520-022-02304-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9702642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2745498593</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-b06292e97bf9a8eb7cc84ae9ce9aca8dc8196919abcd5f315adb21fa16e224dc3</originalsourceid><addsrcrecordid>eNp9kU1PFTEUhhsjEQT-gAvTxI2bkbbT-ejGhNyIkJCQiMKyOdM5c2_JTDu2HYz_nsJFQBcumn68z3nb05eQd5x94ow1R1GySrCCCZFHyWTRviJ7vMlHbcnV6xfrXfI2xhvGJM-bN2S3rGUppVB7BK836Gjy1M-JDj7QOSBOc7K3SMElazyslxGS9Y7-smlDL4-_XRYrf1UIat2A5kGx2WKDdPRuXSQMEzUQkA5g7GiTxXhAdgYYIx4-zvvkx8mX76vT4vzi69nq-LwwUlSp6FgtlEDVdIOCFrvGmFYCKoMKDLS9abmqFVfQmb4aSl5B3wk-AK9RCNmbcp983vrOSzdhb9ClAKOeg50g_NYerP5bcXaj1_5Wq4aJWops8PHRIPifC8akJxsNjiM49EvUosl_zlTDm4x--Ae98Utwub17qpKqrVSZKbGlTPAxBhyeHsOZvk9Rb1PUOUX9kKJuc9H7l208lfyJLQPlFohZcmsMz3f_x_YOR1WpsA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2745498593</pqid></control><display><type>article</type><title>When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Mujahid, Nadia ; Rajan, Ashna ; Abul, Yasin ; Vura, Naga Venkata Rama Krishna ; Neupane, Iva ; LaPlante, Kerry ; Gravenstein, Stefan</creator><creatorcontrib>Mujahid, Nadia ; Rajan, Ashna ; Abul, Yasin ; Vura, Naga Venkata Rama Krishna ; Neupane, Iva ; LaPlante, Kerry ; Gravenstein, Stefan</creatorcontrib><identifier>ISSN: 1720-8319</identifier><identifier>ISSN: 1594-0667</identifier><identifier>EISSN: 1720-8319</identifier><identifier>DOI: 10.1007/s40520-022-02304-8</identifier><identifier>PMID: 36434429</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Anticoagulants ; Anticoagulants - therapeutic use ; Blood Coagulation ; Cardiovascular disease ; Coronaviruses ; COVID-19 ; Disease prevention ; Drug dosages ; Embolisms ; Geriatrics ; Geriatrics/Gerontology ; Hospitalization ; Hospitals ; Humans ; Infections ; Long term health care ; Long-Term Care ; Medicine ; Medicine & Public Health ; Monoclonal antibodies ; Mortality ; Nursing homes ; Older people ; Palliative care ; Pandemics ; Point of View ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Thromboembolism ; Thrombosis</subject><ispartof>Aging clinical and experimental research, 2022-12, Vol.34 (12), p.3171-3177</ispartof><rights>This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022</rights><rights>This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c425t-b06292e97bf9a8eb7cc84ae9ce9aca8dc8196919abcd5f315adb21fa16e224dc3</cites><orcidid>0000-0003-2991-0924</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40520-022-02304-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40520-022-02304-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36434429$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mujahid, Nadia</creatorcontrib><creatorcontrib>Rajan, Ashna</creatorcontrib><creatorcontrib>Abul, Yasin</creatorcontrib><creatorcontrib>Vura, Naga Venkata Rama Krishna</creatorcontrib><creatorcontrib>Neupane, Iva</creatorcontrib><creatorcontrib>LaPlante, Kerry</creatorcontrib><creatorcontrib>Gravenstein, Stefan</creatorcontrib><title>When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities</title><title>Aging clinical and experimental research</title><addtitle>Aging Clin Exp Res</addtitle><addtitle>Aging Clin Exp Res</addtitle><subject>Anticoagulants</subject><subject>Anticoagulants - therapeutic use</subject><subject>Blood Coagulation</subject><subject>Cardiovascular disease</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Disease prevention</subject><subject>Drug dosages</subject><subject>Embolisms</subject><subject>Geriatrics</subject><subject>Geriatrics/Gerontology</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infections</subject><subject>Long term health care</subject><subject>Long-Term Care</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Monoclonal antibodies</subject><subject>Mortality</subject><subject>Nursing homes</subject><subject>Older people</subject><subject>Palliative care</subject><subject>Pandemics</subject><subject>Point of View</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Thromboembolism</subject><subject>Thrombosis</subject><issn>1720-8319</issn><issn>1594-0667</issn><issn>1720-8319</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kU1PFTEUhhsjEQT-gAvTxI2bkbbT-ejGhNyIkJCQiMKyOdM5c2_JTDu2HYz_nsJFQBcumn68z3nb05eQd5x94ow1R1GySrCCCZFHyWTRviJ7vMlHbcnV6xfrXfI2xhvGJM-bN2S3rGUppVB7BK836Gjy1M-JDj7QOSBOc7K3SMElazyslxGS9Y7-smlDL4-_XRYrf1UIat2A5kGx2WKDdPRuXSQMEzUQkA5g7GiTxXhAdgYYIx4-zvvkx8mX76vT4vzi69nq-LwwUlSp6FgtlEDVdIOCFrvGmFYCKoMKDLS9abmqFVfQmb4aSl5B3wk-AK9RCNmbcp983vrOSzdhb9ClAKOeg50g_NYerP5bcXaj1_5Wq4aJWops8PHRIPifC8akJxsNjiM49EvUosl_zlTDm4x--Ae98Utwub17qpKqrVSZKbGlTPAxBhyeHsOZvk9Rb1PUOUX9kKJuc9H7l208lfyJLQPlFohZcmsMz3f_x_YOR1WpsA</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Mujahid, Nadia</creator><creator>Rajan, Ashna</creator><creator>Abul, Yasin</creator><creator>Vura, Naga Venkata Rama Krishna</creator><creator>Neupane, Iva</creator><creator>LaPlante, Kerry</creator><creator>Gravenstein, Stefan</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2991-0924</orcidid></search><sort><creationdate>20221201</creationdate><title>When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities</title><author>Mujahid, Nadia ; Rajan, Ashna ; Abul, Yasin ; Vura, Naga Venkata Rama Krishna ; Neupane, Iva ; LaPlante, Kerry ; Gravenstein, Stefan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-b06292e97bf9a8eb7cc84ae9ce9aca8dc8196919abcd5f315adb21fa16e224dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticoagulants</topic><topic>Anticoagulants - therapeutic use</topic><topic>Blood Coagulation</topic><topic>Cardiovascular disease</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Disease prevention</topic><topic>Drug dosages</topic><topic>Embolisms</topic><topic>Geriatrics</topic><topic>Geriatrics/Gerontology</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infections</topic><topic>Long term health care</topic><topic>Long-Term Care</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Monoclonal antibodies</topic><topic>Mortality</topic><topic>Nursing homes</topic><topic>Older people</topic><topic>Palliative care</topic><topic>Pandemics</topic><topic>Point of View</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Thromboembolism</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mujahid, Nadia</creatorcontrib><creatorcontrib>Rajan, Ashna</creatorcontrib><creatorcontrib>Abul, Yasin</creatorcontrib><creatorcontrib>Vura, Naga Venkata Rama Krishna</creatorcontrib><creatorcontrib>Neupane, Iva</creatorcontrib><creatorcontrib>LaPlante, Kerry</creatorcontrib><creatorcontrib>Gravenstein, Stefan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Aging clinical and experimental research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mujahid, Nadia</au><au>Rajan, Ashna</au><au>Abul, Yasin</au><au>Vura, Naga Venkata Rama Krishna</au><au>Neupane, Iva</au><au>LaPlante, Kerry</au><au>Gravenstein, Stefan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities</atitle><jtitle>Aging clinical and experimental research</jtitle><stitle>Aging Clin Exp Res</stitle><addtitle>Aging Clin Exp Res</addtitle><date>2022-12-01</date><risdate>2022</risdate><volume>34</volume><issue>12</issue><spage>3171</spage><epage>3177</epage><pages>3171-3177</pages><issn>1720-8319</issn><issn>1594-0667</issn><eissn>1720-8319</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>36434429</pmid><doi>10.1007/s40520-022-02304-8</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-2991-0924</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1720-8319 |
| ispartof | Aging clinical and experimental research, 2022-12, Vol.34 (12), p.3171-3177 |
| issn | 1720-8319 1594-0667 1720-8319 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9702642 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Anticoagulants Anticoagulants - therapeutic use Blood Coagulation Cardiovascular disease Coronaviruses COVID-19 Disease prevention Drug dosages Embolisms Geriatrics Geriatrics/Gerontology Hospitalization Hospitals Humans Infections Long term health care Long-Term Care Medicine Medicine & Public Health Monoclonal antibodies Mortality Nursing homes Older people Palliative care Pandemics Point of View SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Thromboembolism Thrombosis |
| title | When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T14%3A44%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=When%20to%20opt%20for%20preemptive%20anticoagulation%20with%20SARS-CoV-2%20infection%20in%20the%20long-term%20care%20facilities&rft.jtitle=Aging%20clinical%20and%20experimental%20research&rft.au=Mujahid,%20Nadia&rft.date=2022-12-01&rft.volume=34&rft.issue=12&rft.spage=3171&rft.epage=3177&rft.pages=3171-3177&rft.issn=1720-8319&rft.eissn=1720-8319&rft_id=info:doi/10.1007/s40520-022-02304-8&rft_dat=%3Cproquest_pubme%3E2745498593%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2745498593&rft_id=info:pmid/36434429&rfr_iscdi=true |